Impact of Donor Activating KIR Genes on HSCT Outcome in C1-Ligand Negative Myeloid Disease Patients Transplanted with Unrelated Donors—A Retrospective Study
Fig 18
Univariate TRM analysis in C1-negative patients with myeloid malignancies who were transplanted with KIR2DS5 positive vs. KIR2DS5 negative donors.
Solid black line: donor KIR2DS5 negative. Dashed orange line: donor KIR2DS5 positive. Donor KIR2DS5-negative (n = 83) vs. donor KIR2D5-positive (n = 34), p = 0.45.